Zobrazeno 1 - 10
of 652
pro vyhledávání: '"neoadjuvant radiotherapy"'
Autor:
Jan Haussmann, Wilfried Budach, Carolin Nestle-Krämling, Sylvia Wollandt, Danny Jazmati, Bálint Tamaskovics, Stefanie Corradini, Edwin Bölke, Alexander Haussmann, Werner Audretsch, Christiane Matuschek
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-17 (2024)
Abstract Background Pathological complete response (pCR) is a well-established prognostic factor in breast cancer treated with neoadjuvant systemic therapy (naST). The determining factors of pCR are known to be intrinsic subtype, proliferation index,
Externí odkaz:
https://doaj.org/article/825f1164356d4e34b3fbefac9c089c49
Autor:
Ihnát P, Martínek L, Tulinský L, Kala Z, Grolich T, Gurlich R, Šturma J, Klos D, Špička P, Neoral Č, Černý V
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 20, Pp 373-379 (2024)
Peter Ihnát,1,2 Lubomír Martínek,1,2 Lubomír Tulinský,1,2 Zdeněk Kala,3 Tomáš Grolich,3 Robert Gurlich,4 Jan Šturma,4 Dušan Klos,5 Petr Špička,5 Čestmír Neoral,2,5 Vladimir Černý6 1Department of Surgery, Univer
Externí odkaz:
https://doaj.org/article/05d9014cf86244ef8c303e562616030f
Autor:
Min Kyu Kang, Soo Yeun Park, Jun Seok Park, Hye Jin Kim, Jong Gwang Kim, Byung Woog Kang, Jin Ho Baek, Seung Hyun Cho, An Na Seo, Duck-Woo Kim, Jin Kim, Se Jin Baek, Ji Hoon Kim, Ji Yeon Kim, Gi Won Ha, Eun Jung Park, In Ja Park, Chang Hyun Kim, Hyun Kang, Gyu-Seog Choi
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Preoperative (chemo)radiotherapy has been widely used as an effective treatment for locally advanced rectal cancer (LARC), leading to a significant reduction in pelvic recurrence rates. Because early administration of intensive ch
Externí odkaz:
https://doaj.org/article/ecbe6a3fcc8b47e5abffaaa0cb5370e2
Publikováno v:
Heliyon, Vol 10, Iss 3, Pp e25461- (2024)
Background: There is a lack of evidence on whether resectable locally advanced gastric cancer (LAGC) patients could benefit from neoadjuvant or adjuvant radiotherapy (RT). Methods: Patients with surgically diagnosed LAGC from 2004 to 2015 were retrie
Externí odkaz:
https://doaj.org/article/0332cccaa5634c3e98da6cf86e0a8712
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
BackgroundMyeloid sarcoma (MS) is a rare hematological malignancy characterized by the formation of a solid mass of myeloblasts outside the bone marrow, such as in the lymph nodes, skin, or bone. MS may arise de novo or concurrently with acute myeloi
Externí odkaz:
https://doaj.org/article/be677f3009a2463f95f5764c8738bb7a
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 10, Pp 753-764 (2023)
Changcheng Tao,1,* Fan Wu,1,* Hongwei Wang,1,* Liming Wang,1 Yue Liu,1 Anke Wu,1 Linlin Zheng,1 Yaru Wang,1 Bo Chen,2 Weiqi Rong,1 Jianxiong Wu1 1Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Cente
Externí odkaz:
https://doaj.org/article/4df0ede4c8854e5db1fdb498db46cddb
Autor:
WANG Anjun, LIU Ningning
Publikováno v:
Shanghai Jiaotong Daxue xuebao. Yixue ban, Vol 43, Iss 3, Pp 320-332 (2023)
Objective·To evaluate the survival effects of neoadjuvant radiation therapy and adjuvant radiotherapy on the patients with rectal cancer treated with chemotherapy and surgery by using the Surveillance, Epidemiology and End Results (SEER) database of
Externí odkaz:
https://doaj.org/article/a617b5ed782f456e94936fa4d0eba847
Autor:
WANG Jun, HE Ping
Publikováno v:
Zhongguo aizheng zazhi, Vol 32, Iss 12, Pp 1229-1234 (2022)
Background and purpose: Perineural invasion is a prognostic factor in colorectal cancer. It is unclear whether perineural invasion is a prognostic factor in in node-negative (ypⅠ-Ⅱ) rectal cancer patients who received neoadjuvant radiotherapy bec
Externí odkaz:
https://doaj.org/article/b528ce6e505c4dc98f1c174777951c29
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Background Neoadjuvant radiotherapy (NRT) for resectable retroperitoneal sarcoma (RPS) has been shown to be systematically feasible. Whether NRT has equivalent or better clinical effects compared to surgery alone for RPS patients remains con
Externí odkaz:
https://doaj.org/article/098de087ced543178764123b9b4c539a
Autor:
Siyer Roohani, Felix Ehret, Marta Kobus, Anne Flörcken, Sven Märdian, Jana Käthe Striefler, Daniel Rau, Robert Öllinger, Armin Jarosch, Volker Budach, David Kaul
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-19 (2022)
Abstract Background Soft tissue sarcomas (STS) represent a diverse group of rare malignant tumors. Currently, five to six weeks of preoperative radiotherapy (RT) combined with surgery constitute the mainstay of therapy for localized high-grade sarcom
Externí odkaz:
https://doaj.org/article/b69bd41d2e194ecbb1ce911a409585de